May 07, 2024
  • Novartis Healthcare Philippines and AC Health have launched their Integrated Cardiovascular and Cancer Care partnership that aims to broaden access to innovative medicines for breast cancer, heart failure and high cholesterol, as well as to empower the patient community

Novartis Healthcare Philippines and AC Health have launched an Integrated Cardiovascular and Cancer Care partnership that aims to broaden access to innovative medicines for breast cancer, heart failure and high cholesterol, as well as to empower the patient community. 

“Novartis is committed to get the right treatment to the right patient at the right time as quickly as possible. As such, we are pleased to partner with leading integrated healthcare provider AC Health in achieving our shared goal of broadening access to life-saving innovative medicines and empowering the patient community,” said Mr. Joel Chong, Country President of Novartis Healthcare Philippines.

“By bringing together the strengths of the entire AC Health ecosystem and the world-class cancer care and cardiology medications of Novartis, we are able to offer best value treatment, while continuing to offer quality care,” said Mr. Paolo Borromeo, President & CEO, AC Health.

The partnership aims to broaden access to innovative medicines by co-creating healthcare solutions for better patient outcomes. These include promoting patient awareness on breast cancer, heart failure, and high cholesterol, among others, to improve treatment adherence and patient outcomes; enhance healthcare professionals’ knowledge and understanding on the aforementioned disease areas and improve their capacity to manage patients; and enhance patient adherence through value-added services (e.g., health financing, patient reminders and monitoring etc.) which will help improve patient outcomes.

Novartis, AC Health launch Integrated Cardiovascular and Cancer Care partnership
Photo shows (from left): Atty. Yet A. Abarca, President and CEO, AHCHI Pharma Ventures Inc.; Jimmy E. Ysmael, President and CEO Healthway Medical Network; Paolo F. Borromeo, President and CEO, AC Health; Joel Chong, Country President, Novartis Healthcare Philippines; Gaurav Dass, Chief Financial Officer, Novartis Healthcare Philippines; and Andres Clemente, Therapeutic Head for Immunology, Solid Tumor and Hematology, Novartis Healthcare Philippines.

 

About AC Health 

Ayala Healthcare Holdings, Inc. (AC Health) is a wholly-owned subsidiary of the Ayala Corporation that aims to provide every Filipino accessible, affordable, and quality healthcare. Its portfolio includes Generika Drugstore, the pioneer in generic retail pharmacies, IE Medica and MedEthix, a major pharmaceutical importer and distributor, Healthway Medical Network, a network of multi-specialty clinics, ambulatory centers, and full-service hospitals, and KonsultaMD, a healthcare aggregator app that offers online consultations, medicine delivery, and clinic and diagnostic booking. Through its three pillars—pharma, hospitals and clinics, and digital health—AC Health creates a seamless and integrated healthcare ecosystem for the Filipino patient. 

For information: 
Rafa Abaya 
Email: [email protected]

 

About Novartis

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.

 

Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis

For Novartis multimedia content, please visit www.novartis.com/news/media-library

For questions about the site or required registration, please contact [email protected]

 

Contact Persons

Christine Fajardo

Communications & Engagement Head, Philippines & Asia Aspiring Innovative Medicines  

Maribella Grace Sonsona

Communications Manager